Showing 4881-4890 of 10638 results for "".
Cutting Through the Chatter: How to Interrupt Others Politely
https://reachmd.com/programs/speaking-of/cutting-through-chatter-how-interrupt-others-politely/8518/Karen Friedman outlines some effective interrupting strategies to help convey your points in a crowded room.Weekly Check-up | August 15th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-august-15th-2016/8282/Welcome to the Weekly Check-up on ReachMD for the week of August 15th, 2016.Weekly Check-up | June 27th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-june-27th-2016/8192/Welcome to the Weekly Check-up on ReachMD for the week of June 27th, 2016.Weekly Check-up | June 6th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-june-6th-2016/8159/Welcome to the Weekly Check-up on ReachMD for the week of June 6th, 2016.Weekly Check-up | April 25th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-april-25th-2016/8063/Welcome to the Weekly Check-up on ReachMD for the week of April 25th, 2016.Weekly Check-up | April 18th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-april-18th-2016/8055/Welcome to the Weekly Check-up on ReachMD for the week of April 18th, 2016.An FDA Retrospective with Past Commissioner Dr. Margaret Hamburg
https://reachmd.com/programs/conversations-on-health-care/fda-retrospective-past-commissioner-dr-margaret-hamburg/7603/This week, Mark Masselli and Margaret Flinter speak with Dr. Margaret Hamburg, Foreign Secretary for the National Academy of Medicine at the National Academy of Sciences and recent Commissioner of the US Food and Drug Administration. Dr. Hamburg discusses the changes initiated at the FDA under her lUpdates from the "Pulmonary Pipeline" of COPD Drug Developments
https://reachmd.com/programs/clinicians-roundtable/updates-pulmonary-pipeline-copd-drug-developments/7413/In today's clinical practice, there is no appropriate "one size fits all" treatment approach for COPD. But while this progressive trend toward personalized medicine standards helps optimize COPD care for each patient, the cost-to-benefit ratio for drug development changes as COPD evolves from one di"Overcoming Obamacare:" Health Policy Perspectives with Author Philip Klein
https://reachmd.com/programs/voices-from-american-medicine/overcoming-obamacare-health-policy-perspectives-author-philip-klein/7284/“One cannot understand policy without appreciating the philosophy that is driving it.” That’s a passage taken from author Philip Klein's book, Overcoming Obamacare: Three Approaches to Reversing the Government Takeover of Health Care. Mr. Klein is commentary editor of the Washington Examiner, whereMedication Guides
https://reachmd.com/programs/FDA-Drug-Information-Updates/medication-guides/7233/Questions have arisen concerning FDA's recommendations for providing a Medication Guide to a patient when the drug is dispensed to a health care professional who then administers the drug to the patient. In some cases, these drugs are administered to a patient several times a day or several times a